Life Science · Pharma
Agmine Pharma AB
The problem
Many children are at risk of developing allergies due to insufficient immune maturation early in life, leading to long-term health issues and increased healthcare burdens.
Value Proposition
Agmine Pharma provides a preventive biologic that helps reduce children's risk of developing allergies by promoting immune maturation early in life.
Allergies in children
Sara Lorentzon
sara.lorentzon@ventures.gu.se